Related content

Evaluation of endothelial dysfunction, lipid metabolism in women with polycystic ovary syndrome: relationship of paraoxonase 1 activity, malondialdehyde levels, low-density lipoprotein subfractions, and endothelial dysfunction

By Bayram Fahri   Kocer Derya   Ozsan Muge   Muhtaroglu Sabahattin  

Gynecological Endocrinology, Vol. 28, Iss. 7, 2012-07 ,pp. : 497-501

Informa Healthcare

Access to resources Recommend Favorite

Uterine effects of metformin administration in anovulatory women with polycystic ovary syndrome

By Palomba Stefano   Russo Tiziana   Orio Francesco   Falbo Angela   Manguso Francesco   Cascella Teresa   Tolino Achille   Carmina Enrico   Colao Annamaria   Zullo Fulvio  

Human Reproduction, Vol. 21, Iss. 2, 2006-02 ,pp. : 457-465

Oxford University Press

Access to resources Recommend Favorite

Effects of metformin treatment in women with polycystic ovary syndrome depends on insulin resistance

By Nawrocka Jolanta   Starczewski Andrzej  

Gynecological Endocrinology, Vol. 23, Iss. 4, 2007-04 ,pp. : 231-237

Informa Healthcare

Access to resources Recommend Favorite

Pioglitazone and metformin in obese women with polycystic ovary syndrome not optimally responsive to metformin

By Glueck Charles J.   Moreira Andrew   Goldenberg Naila   Sieve Luann   Wang Ping  

Human Reproduction, Vol. 18, Iss. 8, 2003-08 ,pp. : 1618-1625

Oxford University Press

Access to resources Recommend Favorite

Microvascular dysfunction in women with polycystic ovary syndrome

By Lakhani K.   Leonard A.   Seifalian A.M.   Hardiman P.  

Human Reproduction, Vol. 20, Iss. 11, 2005-11 ,pp. : 3219-3224

Oxford University Press

Access to resources Recommend Favorite